Advertisement
Persons > All
Total search results: 2420 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Fortier, Denis (Eurobio Scientific 202208 Deputy Managing Director + Co-CEO + Chairman of EurobioNext) | Managing Director | Eurobio Scientific (Group) | Île-de-France (region) |
Fossiez, Nicolas (NewCap 202307) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
Foussat, Arnaud (Yukin Therapeutics 201906 CEO + Advent France Biotechnology 201707– Operating Partner before TxCell) | Partner (venture partner) | AdBio Partners (Group) | Île-de-France (region) |
Fraichard, Alexandre (genOway 200610 CEO + Co-Founder) | Chief Executive Officer (CEO) | genOway (Group) | Auvergne-Rhône-Alpes (region) |
François, Fabienne (Theradiag 201705 CFO) | Chief Financial Officer (CFO) | Theradiag (Group) | Île-de-France (region) |
Frank, Michael (Agilent 201306 Senior Director Global Marketing Liquid Phase Separations Business) | Sales Manager / Marketing Manager | Agilent (Group) | Baden-Württemberg (federal state) |
Frearson, Julie (Charles River 201711 Corp VP Global Discovery Services) | President/Director/Head Business Group/Unit/Division | Charles River (Group) | Massachusetts (federal state) |
Freedland, Cory S. (Samsara BioCapital 202007 Principal before Sofinnova 201703 at Sofinnnova Ventures) | Principal (venture capital) | Samsara BioCapital (US) | California (federal state) |
Freeman, Gordon (Harvard Univ 202301 at Dana-Farber Cancer Institute + Academic Founder of NextPoint Tx) | Researcher (university / research institute) | Harvard University | United States (USA)_o |
Freitag, Chris (Dynacure 201807– CMO before Debioparm + BTG plc + Shire + Roche) | Chief Medical Officer (CMO) | Dynacure SAS | Grand Est (Great East) (region) |
Frérot, Antoine (Veolia Environnement 201303 CEO) | Chief Executive Officer (CEO) | Veolia (Group) | Île-de-France (region) |
Freyssinet, Georges (LemnaGene –200507 CEO thereafter Director RnD) | Research & Development Manager | Biolex (Group) | Auvergne-Rhône-Alpes (region) |
Frohna, Paul (ImCheck Therapeutics 201907– CMO before Bioniz Therapeutics + Receptos + ProFibrix + Fibrogen + Genentech) | Chief Medical Officer (CMO) | ImCheck Therapeutics SAS | Provence-Alpes-Côte d’Azur (region) |
Frouin, Pierre (BioSerenity 201506 CEO) | Chief Executive Officer (CEO) | BioSerenity (FR) | Île-de-France (region) |
Fry, Hugo (RQ Biotechnology 202205– CEO before Imbria + Sanofi UK) | Chief Executive Officer (CEO) | RQ Biotechology Ltd. | Greater London (region) |
Fuchs, Alexandra (Cytoo 201109 COO) | Chief Operating Officer (COO) | Cytoo (Group) | Auvergne-Rhône-Alpes (region) |
Fukuda, Toru (Interprotein Corp 201511 CFO) | Chief Financial Officer (CFO) | Interprotein Corporation (JP) | Kinki (region) |
Fulton, Gemma (BioOutsource 201406 Sales + Marketing Associate) | Sales Manager / Marketing Manager | Sartorius (Group) | Scotland |
Furfine, Eric S. (ImmuneXcite 201603– CSO + acting CEO before Eleven Biotherapeutics + Adnexus + Regeneron + GSK) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ImmuneXcite Inc. | Massachusetts (federal state) |
Futerman, Anthony (Weizmann Institute 202007 Professor) | Professor | Weizmann Institute of Science | Israel_o |
Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) | Professor | Max Planck Society for the Advancement of Science | |
Gaal, Lubor (Targovax 202203– CFO before Locust Walk + Almirall + BMS + Neuro3d + Vectron Therapeutics) | Chief Financial Officer (CFO) | Circio (Group) | Østlandet (Eastern Norway) (region) |
Gabard, Jérôme (Pherecydes Pharma 201801 COO former CEO) | Chief Operating Officer (COO) | Pherecydes Pharma S.A. (Euronext Paris: ALPHE) | Île-de-France (region) |
Gabriel, Raimund (MC Services 1999–201101– Founder + CEO) | Chief Executive Officer (CEO) | MC Services AG | Bayern (federal state) |
Gaillard, Mariette (Medicalps 201509 Communication Manager) | Public Relations Manager / Investor Relations Manager | Medicalps Association | Auvergne-Rhône-Alpes (region) |
Gaillard, Pierre (Servier 201702 Director of Global Marketing) | Sales Manager / Marketing Manager | Servier (Group) | Île-de-France (region) |
Gaiotto, Michele (Zambon 202211 CEO of HTH VC) | Chief Executive Officer (CEO) | Zambon (Group) | |
Galbraith, Kenneth (AnorMED 200610 Chairman + Interim CEO) | Board member, non-executive | Sanofi (Group) [since May 2011] | British Columbia |
Galon, Jérôme (INSERM 201507 + Co-Founder of HalioDx) | Researcher (university / research institute) | France (govt) | Île-de-France (region) |
Gamst, Jesper (VBM Laboratoriet A/S 201703 Managing Director + Co-Owner) | Managing Director | Eurofins (Group) | Denmark_o |
Gangloff, Aurore (Alize RP 201803) | Public Relations Manager / Investor Relations Manager | Deinove S.A. (Euronext Growth: ALDEI.PA) | Île-de-France (region) |
Garaud, Jean-Jacques (Inotrem 201403 CEO before Roche –201206 Global Head pRED) | President/Director/Head Business Group/Unit/Division | Inotrem S.A. | Île-de-France (region) |
Garcia, Jean Charles (Picometrics 201401 President) | President/Director/Head Business Group/Unit/Division | Picometrics (Group) | Occitanie (Occitania) (region) |
Garcia-Janin, Maxime (Sillages Paris 201812 Founder) | Company Founder | Sillages Paris SAS | Île-de-France (region) |
Garçon, Benjamin (Goodwin Procter 202104 Partner at Paris Office) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
Garçon, Nathalie (BIOASTER 202002 CEO) | Chief Executive Officer (CEO) | BIOASTER (FR, Technology Research Institute – TRI) | Auvergne-Rhône-Alpes (region) |
Gardès, Vincent (Vexim 201404 CEO) | Chief Executive Officer (CEO) | Vexim (Group) | Occitanie (Occitania) (region) |
Gardette, Jacques (Biocorp (FR) 201507 President/CEO + Founder) | Chief Executive Officer (CEO) | Biocorp (Alternext: ALCOR) | Auvergne-Rhône-Alpes (region) |
Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
Gariel, Sylvain (DNA Script 201709 COO + Co-Founder) | Chief Operating Officer (COO) | DNA Script (Group) | Île-de-France (region) |
Garijo, Belén (Merck (DE) 202007– promoted Deputy CEO before CEO of Merck Serono before COO before Sanofi) | Chief Executive Officer (CEO) | Merck (DE) (Group) | Hessen (Hesse) (federal state) |
Garland, Ian (Vernalis 200812– CEO before Acambis CEO + Arrow Therapeutics CFO + Celltech Pharmaceuticals Inc) | Chief Executive Officer (CEO) | Vernalis (Group) | United Kingdom (state/region unspecified) |
Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (state/region unspecified) |
Garnier, Olivier (Bryan Garnier 201709 Managing Partner) | Managing Partner | Bryan, Garnier & Co., Ltd. | Greater London (region) |
Garufi, Michele (NicOx 200809 Chairman + CEO) | Chief Executive Officer (CEO) | Nicox (Group) | Provence-Alpes-Côte d’Azur (region) |
Garvey, Cathal (Forma Labs 201610 Founder) | Company Founder | Forma Labs (IE) | Ireland (cl4) |
Gaston-Mathé, Yann (Iktos 201904 CEO + Co-Founder) | Chief Executive Officer (CEO) | Iktos SAS | Île-de-France (region) |
Gates, William Henry (Bill), III | n. a. | GATES Group (family of Bill Gates) | United States (USA)_o |
Gatzemeier, Susanne (Global Fairs 201504) | n. a. | Global Fairs (FR) | Île-de-France (region) |
Gaubert, Sarah (Nanobiotix 201603 Head Communication + Public Affairs) | Public Relations Manager / Investor Relations Manager | Nanobiotix (Group) | Île-de-France (region) |
Gauci, Mark (BTF Pty Ltd 200709 CEO + co-founder) | Chief Executive Officer (CEO) | Mérieux (Group) | New South Wales (NSW) |
Gauer, Christoph (EliTech Group 202312 CEO before Siemens + Olympus + Advalytix) | Chief Executive Officer (CEO) | Elitech (Group) | Île-de-France (region) |
Gaultier, Pierre-Emmanuel (TreeFrog Therapeutics 202006 Marketing + Communciations Manager) | Sales Manager / Marketing Manager | TreeFrog Therapeutics (Group) | Nouvelle-Acquitaine (New Acquitaine) (region) |
Gay-Crosier, Chris (Investiere 201909 Head of International Investments) | Investment Manager | Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) | Central Switzerland (region) |
Gea, Manuel (Bio-Modeling Systems 201509 CEO + Co-Founder) | Chief Executive Officer (CEO) | Bio-Modeling Systems (BMSystems) (FR) | Île-de-France (region) |
Gebauer, Alexander (Secarna 202102– Managing Director (CEO) before Omeicos + Sun Pharma + Ranbaxy + Merz Pharma) | Chief Executive Officer (CEO) | Secarna (Group) | Bayern (federal state) |
Gemayel, Georges (201511 Non-executive Board Member of Supernus + Rapotr + Dimension + Enterome + OxThera + Orphazyme) | Board member, non-executive | Enterome S.A. | Île-de-France (region) |
Genee, Hans (Biosyntia 201610 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Biosyntia ApS | Denmark_o |
Geneste, Olivier (Servier 201703 Director of Oncology Research) | President/Director/Head Business Group/Unit/Division | Servier (Group) | Île-de-France (region) |
Génin, Bérengère (IntegraGen 201811 Director of Bioinformatics) | n. a. | OncoDNA (Group) | Île-de-France (region) |
Genne, Philippe (Oncodesign 201209 CEO + Founder) | Chief Executive Officer (CEO) | Oncodesign S.A. (Alternext: ALONC) | Bourgogne-Franche-Comté (Burgundy-Free County) (region) |
Geoghegan-Quinn, Máire (EU (govt) 201103 Commissioner for Research, Innovation and Science) | Administrative Officer (personnel) | EU (govt) | Brussels (region) |
George, Tad (RareCyte 202006 SVP of Biology RnD) | Research & Development Manager | RareCyte Inc. | Washington (federal state) |
Gerard, Pierre-Emmanuel (Biomunex 2014– CEO + Co-Founder) | Chief Executive Officer (CEO) | Biomunex Pharmaceuticals SASU | Île-de-France (region) |
Germain, Matthieu (Nanobiotix 201905– CEO of Curadigm) | Chief Executive Officer (CEO) | Nanobiotix (Group) | |
Germain, Pierre-Louis (Ulysee Communication 202306) | Public Relations Manager / Investor Relations Manager | Ulysse Communication GIE | Île-de-France (region) |
Gervat, Vincent (Sanofi 201407 RnD France) | Research & Development Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Giabicani, Gabriel (France (govt) 202112 Director Operation + Innovation at Investment Dept of Banque des Territoires) | n. a. | France (govt) | France (region/state unspecified) |
Gidoin, Thomas (GenSight Biologics 201507 CFO) | Chief Financial Officer (CFO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
Gilly, Bernard (GenSight Biologics 201304 CEO + Co-founder before Fovea + Sofinnova Partners + Transgene) | Chief Executive Officer (CEO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
Girard, Wilfrid (Medeuronet 201705 CEO + Founder) | Chief Executive Officer (CEO) | Medeuronet SAS | Grand Est (Great East) (region) |
Giraut, Claire (Mérieux 201309– designated future CFO of bioMérieux before Ipsen + Europcar) | Chief Financial Officer (CFO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
Gitzinger, Marc (BioVersys 2008– CEO + Co-founder) | Chief Executive Officer (CEO) | BioVersys AG | Northwestern Switzerland (region) |
Glaser, Patrick (Novasep 201210–201306 CEO before Head Novasep Synthesis division since 5/10 LEFT 6/13) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
Glezer, Stan (Adocia 201804 CMO) | Chief Medical Officer (CMO) | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
Glocer, Thomas H. (Tom) (Thomson-Reuters 200804 CEO) | Chief Executive Officer (CEO) | Thomson (Group) | France (region/state unspecified) |
Goarant, Cédric (13advisory 201509 Managing Partner) | Managing Partner (investment firm) | 13advisory (FR) | Auvergne-Rhône-Alpes (region) |
Godard, Alain (EU (govt) 202301– Chairman of the European Tech Champion Initiative before Chief Executive of EIF) | Chief Executive Officer (CEO) | EU (govt) | Brussels (region) |
Godard, Augustin (INSERM 201509 Open Innovation Manager at Inserm Transfert) | Business Development Manager / Strategy Manager | France (govt) | Île-de-France (region) |
Godet, Vanessa (France (govt) 201509 Media Relations Manager at bpifrance) | Public Relations Manager / Investor Relations Manager | France (govt) | Île-de-France (region) |
Goemaere, Wim (Bone Therapeutics 201309– CFO before Devgen CFO + VIB CFO) | Chief Financial Officer (CFO) | Bone Therapeutics (Group) | Wallonia (region) |
Goff, Marcia (Thermo Fisher –201805 LEFT) | n. a. | Thermo Fisher (Group) | Massachusetts (federal state) |
Goffart, Lucien (Robocath 202004 CEO) | Chief Executive Officer (CEO) | Robocath SAS | Normandie (Normandy) (region) |
Gohaud, Romain (Theravectys 201310 CFO) | Chief Financial Officer (CFO) | Theravectys S.A. | Île-de-France (region) |
Goineau, Pierre-Olivier (Erytech Pharma 201412 CEO + Co-founder + Chair of France Biotech) | Chief Executive Officer (CEO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
Golaz, Louis (RED Horticulture 202311 CEO + Co-Founder) | Chief Executive Officer (CEO) | RED Horticulture (Rouge Engineered Designs) (Group) | Auvergne-Rhône-Alpes (region) |
Goldsmith, Mark A. (Revolution Medicines 201807 CEO) | Chief Executive Officer (CEO) | Revolution Medicines Inc. (RVMD) | California (federal state) |
Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) | Chief Executive Officer (CEO) | Sundew ApS | Hovedstaden |
Goldwasser, Isy (Symyx 200801 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | California (federal state) |
Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) | General Manager (management) | Merck (DE) (Group) | Auvergne-Rhône-Alpes (region) |
Gonzalez Aseguinolaza, Gloria (Vivet Therapeutics 201705 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vívet Therapeutics (Group) | Île-de-France (region) |
Gonzalez, Céline (Andrew Loyd and Associates 2013) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | Île-de-France (region) |
Gonzalo, Teresa (Ambiox Biotech 201509 CEO) | Chief Executive Officer (CEO) | Ambiox Biotech (ES) | Castila and León |
Goossens, Herman (Univ Antwerp 201904 Professor at Laboratory of Medical Microbiology) | Professor | University of Antwerp | Flanders (Flemish region) |
Goppelsroeder, Christoph (DSM 201506 CEO of DSM Nutritional Products) | Chief Executive Officer (CEO) | DSM (Group) | United States (USA)_o |
Goretti, Letizia (Alia Therapeutics 202305– CEO before JnJ Innovation Centre London + BMS Italy) | Chief Executive Officer (CEO) | Alia Therapeutics S.r.l. | Lombardia (Lombardy) |
Goupit, Philippe (MedDay 201501– Non-executive Board Director before Sanofi VP Corporate Licenses) | Board member, non-executive | MedDay Pharmaceuticals SAS | Île-de-France (region) |
Gouy, Michel (JSP Partners 201207 Partner) | n. a. | JSB Partners L.P. | |
Gouze, Elvire (InnoSkel 202012 CEO + Founder + INSERM + before TherAchon) | Chief Executive Officer (CEO) | InnoSkel SAS | Provence-Alpes-Côte d’Azur (region) |
Grabert, Sebastian (Euronext 201709 Director Germany Representative before HSCBC + Berenberg) | Sales Manager / Marketing Manager | Euronext (Group) | North Holland (province, NL) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top